GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NEOFECT Co Ltd (XKRX:290660) » Definitions » EV-to-FCF

NEOFECT Co (XKRX:290660) EV-to-FCF : -25.75 (As of Apr. 24, 2025)


View and export this data going back to 2018. Start your Free Trial

What is NEOFECT Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, NEOFECT Co's Enterprise Value is ₩37,587 Mil. NEOFECT Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,459 Mil. Therefore, NEOFECT Co's EV-to-FCF for today is -25.75.

The historical rank and industry rank for NEOFECT Co's EV-to-FCF or its related term are showing as below:

XKRX:290660' s EV-to-FCF Range Over the Past 10 Years
Min: -36.93   Med: -9.49   Max: -2.03
Current: -25.48

During the past 9 years, the highest EV-to-FCF of NEOFECT Co was -2.03. The lowest was -36.93. And the median was -9.49.

XKRX:290660's EV-to-FCF is ranked worse than
100% of 388 companies
in the Medical Devices & Instruments industry
Industry Median: 25.065 vs XKRX:290660: -25.48

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-24), NEOFECT Co's stock price is ₩929.00. NEOFECT Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-92.898. Therefore, NEOFECT Co's PE Ratio (TTM) for today is At Loss.


NEOFECT Co EV-to-FCF Historical Data

The historical data trend for NEOFECT Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NEOFECT Co EV-to-FCF Chart

NEOFECT Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -7.72 -12.62 -9.24 -10.63 -24.38

NEOFECT Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.63 -12.95 -6.55 -7.30 -24.38

Competitive Comparison of NEOFECT Co's EV-to-FCF

For the Medical Devices subindustry, NEOFECT Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NEOFECT Co's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NEOFECT Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where NEOFECT Co's EV-to-FCF falls into.


;
;

NEOFECT Co EV-to-FCF Calculation

NEOFECT Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=37587.008/-1459.46
=-25.75

NEOFECT Co's current Enterprise Value is ₩37,587 Mil.
NEOFECT Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,459 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NEOFECT Co  (XKRX:290660) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

NEOFECT Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=929.00/-92.898
=At Loss

NEOFECT Co's share price for today is ₩929.00.
NEOFECT Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-92.898.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


NEOFECT Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of NEOFECT Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NEOFECT Co Business Description

Traded in Other Exchanges
N/A
Address
152, Jukjeon-ro, 401 West Hall, Dankook, University, 152, Suji-gu, Gyeonggi-do, Yongin-si, KOR
NEOFECT Co Ltd is a Korea based company engaged in developing rehab training products and services. The company has developed innovative smart rehabilitation solutions to help patients with neurological and musculoskeletal injuries. Products offered by the company include RAPAEL Smart Glove, RAPAEL Smart Kids, RAPAEL Smart Board, RAPAEL SMART PEGBOARD, RAPAEL Cognition, NeoMano, and RAPAEL Suite.

NEOFECT Co Headlines

No Headlines